Citius Pharmaceuticals (CTXR) Finished Goods (2024 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Finished Goods came in at $15.7 million in Q1 2026, little changed on a QoQ basis from $15.7 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Finished Goods (2024 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 3 years of Finished Goods data on file, last reported at $15.7 million in Q1 2026.
- Quarterly Finished Goods changed N/A year-over-year to $15.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (changed N/A YoY) and the FY2025 annual result came in at $10.6 million, up 72.42% from the prior year.
- Finished Goods was little changed at $15.7 million in Q1 2026, from $15.7 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $15.7 million in Q1 2026 to a low of $6.1 million in Q3 2024.
- A 3-year average of $12.0 million and a median of $13.1 million in 2025 frame the typical range for Finished Goods.
- The widest YoY moves for Finished Goods: up 72.42% in 2025, down 72.42% in 2025.
- Tracing CTXR's Finished Goods over 3 years: stood at $6.1 million in 2024, then jumped by 155.71% to $15.7 million in 2025, then rose by 0.13% to $15.7 million in 2026.
- The last three Finished Goods figures came in at $15.7 million (Q1 2026), $15.7 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Citius Pharmaceuticals | 15.82 Mn | 15.82 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 10.58 Mn |
| Sep 30, 2024 | 6.13 Mn |